- $1.98bn
- $2.11bn
- $620.41m
- 65
- 81
- 74
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 469 | 481 | 497 | 553 | 576 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 459 | 481 | 530 | 543 | 565 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 183 | 142 | 247 | 241 | 227 |
Provision for Income Taxes | |||||
Net Income After Taxes | 146 | 116 | 201 | 195 | 184 |
Net Income Before Extraordinary Items | |||||
Net Income | 146 | 116 | 201 | 195 | 184 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 146 | 116 | 201 | 195 | 184 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.36 | 4.95 | 5.84 | 5.5 | 5.33 |
Dividends per Share | |||||
Special Dividends per Share |